ArticleThe oncologist2025

Predictors of outcomes in advanced non-small cell lung cancer treated with pembrolizumab maintenance.

Vamsidhar Velcheti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.